All Stories

  1. Urokinase‐type plasminogen activator receptor (uPAR) on tumor‐associated macrophages is a marker of poor prognosis in colorectal cancer

    Article • Cancer Medicine, May 2014, Wiley

    Dr Martin Illemann

  2. Time-dependent biological differences in molecular markers of high-grade urothelial cancer over 7 decades (ras proteins, pTEN, uPAR, PAI-1 and MMP-9)

    Article • Virchows Archiv, October 2012, Springer Science + Business Media

    Dr Martin Illemann

  3. Urokinase‐Type Plasminogen Activator, Its Receptor and Inhibitor as Biomarkers in Cancer

    Article • June 2012, Wiley

    Dr Martin Illemann

  4. Histopathological Growth Pattern, Proteolysis and Angiogenesis in Chemonaive Patients Resected for Multiple Colorectal Liver Metastases

    Article • Journal of Oncology, January 2012, Hindawi Publishing Corporation

    Dr Martin Illemann, Professor Ben Vainer

  5. uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy

    Article • Current Drug Targets, November 2011, Bentham Science Publishers

    Dr Martin Illemann

  6. Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry

    Article • International Journal of Cancer, October 2011, Wiley

    Dr Martin Illemann

  7. Urokinase plasminogen activator receptor on invasive cancer cells: A prognostic factor in distal gastric adenocarcinoma

    Article • International Journal of Cancer, October 2011, Wiley

    Dr Martin Illemann, Dr Eric Santoni-Rugiu

  8. Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling

    Article • Developmental Biology, October 2011, Elsevier

    Dr Martin Illemann

  9. Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma

    Article • International Journal of Cancer, August 2011, Wiley

    Dr Martin Illemann, Dr Eric Santoni-Rugiu

  10. Purification and characterization of recombinant full-length and protease domain of murine MMP-9 expressed in Drosophila S2 cells

    Article • Protein Expression and Purification, July 2010, Elsevier

    Dr Martin Illemann

  11. Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high- and low-risk countries

    Article • International Journal of Cancer, January 2010, Wiley

    Dr Martin Illemann

  12. Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori

    Article • Virchows Archiv, September 2009, Springer Science + Business Media

    Dr Martin Illemann

  13. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases

    Article • International Journal of Cancer, April 2009, Wiley

    Dr Martin Illemann

  14. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies

    Article • Journal of Immunological Methods, November 2008, Elsevier

    Dr Martin Illemann

  15. Crohn's Disease But Not Chronic Ulcerative Colitis Induces the Expression of PAI-1 in Enteric Neurons

    Article • The American Journal of Gastroenterology, September 2008, Wolters Kluwer Health

    Dr Martin Illemann

  16. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor

    Article • International Journal of Cancer, February 2007, Wiley

    Dr Martin Illemann

  17. Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma

    Article • International Journal of Cancer, January 2007, Wiley

    Dr Martin Illemann

  18. Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma

    Article • International Journal of Cancer, September 2004, Wiley

    Dr Martin Illemann

  19. Leading-Edge Myofibroblasts in Human Colon Cancer Express Plasminogen Activator Inhibitor-1

    Article • American Journal of Clinical Pathology, August 2004, Oxford University Press (OUP)

    Dr Martin Illemann